Flex Pharma, Inc. (NASDAQ: FLKS):
Click
to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is
developing innovative and proprietary treatments for nocturnal leg
cramps and spasms associated with severe neuromuscular conditions, today
announced that it will present a corporate overview at the following
upcoming healthcare investor conferences in June:
-
The Jefferies Global Healthcare Conference on June 4, 2015 at 1:30
p.m. ET in New York, NY; and
-
The JMP Life Sciences Conference on June 24, 2015 at 2:00 p.m. ET in
New York, NY.
A live webcast of Flex Pharma’s presentations at these conferences may
be accessed in the Investor section of the Company’s website at www.flex-pharma.com.
Please log on to the Flex Pharma website approximately 15 minutes prior
to the scheduled webcast to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be
available on Flex Pharma’s website for 2 weeks following each
presentation.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for exercise-associated muscle
cramps, nocturnal leg cramps, and spasms associated with severe
neuromuscular conditions. In three randomized, blinded,
placebo-controlled, cross-over studies, Flex Pharma's proprietary
treatment has shown a statistically significant reduction in the
intensity of muscle cramps in healthy normal volunteers.
Flex Pharma was founded by National Academy of Sciences members Rod
MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized
leaders in the fields of ion channels and neurobiology, along with
Chairman and Chief Executive Officer Christoph Westphal, M.D., Ph.D.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150528005815/en/
Copyright Business Wire 2015